Log in

Varian Medical Systems Stock Forecast, Price & News

-0.21 (-0.12 %)
(As of 11/27/2020 12:00 AM ET)
Today's Range
Now: $173.90
50-Day Range
MA: $172.86
52-Week Range
Now: $173.90
Volume557,184 shs
Average Volume1.03 million shs
Market Capitalization$15.81 billion
P/E Ratio56.65
Dividend YieldN/A
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates in Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy after loaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with Siemens AG; partnership agreement with The National University Cancer Institute; and a strategic collaboration with Telix Pharmaceuticals for advanced prostate imaging. Varian Medical Systems was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.
Read More
Varian Medical Systems logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.9Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.41 out of 5 stars

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment



Sales & Book Value

Annual Sales$3.23 billion
Cash Flow$5.78 per share
Book Value$19.52 per share


Net Income$291.90 million


Market Cap$15.81 billion
Next Earnings Date2/3/2021 (Estimated)
-0.21 (-0.12 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Varian Medical Systems (NYSE:VAR) Frequently Asked Questions

How has Varian Medical Systems' stock price been impacted by COVID-19 (Coronavirus)?

Varian Medical Systems' stock was trading at $113.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, VAR shares have increased by 53.8% and is now trading at $173.90.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Varian Medical Systems?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Varian Medical Systems in the last year. There are currently 3 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Varian Medical Systems
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Varian Medical Systems?

Wall Street analysts have given Varian Medical Systems a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Varian Medical Systems wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Varian Medical Systems' next earnings date?

Varian Medical Systems is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Varian Medical Systems

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) issued its quarterly earnings data on Tuesday, October, 27th. The medical equipment provider reported $1.12 EPS for the quarter, beating the consensus estimate of $0.98 by $0.14. The medical equipment provider earned $850.50 million during the quarter, compared to analysts' expectations of $831.63 million. Varian Medical Systems had a return on equity of 19.68% and a net margin of 8.82%. During the same period last year, the business earned $1.21 EPS.
View Varian Medical Systems' earnings history

What price target have analysts set for VAR?

9 equities research analysts have issued twelve-month price targets for Varian Medical Systems' stock. Their forecasts range from $90.00 to $178.00. On average, they expect Varian Medical Systems' stock price to reach $148.28 in the next year. This suggests that the stock has a possible downside of 14.7%.
View analysts' price targets for Varian Medical Systems

Are investors shorting Varian Medical Systems?

Varian Medical Systems saw a drop in short interest in the month of October. As of October 30th, there was short interest totaling 2,210,000 shares, a drop of 58.1% from the October 15th total of 5,280,000 shares. Based on an average trading volume of 1,320,000 shares, the days-to-cover ratio is currently 1.7 days. Approximately 2.4% of the shares of the stock are short sold.
View Varian Medical Systems' Short Interest

Who are some of Varian Medical Systems' key competitors?

What other stocks do shareholders of Varian Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Varian Medical Systems investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), Pfizer (PFE), Abbott Laboratories (ABT), CVS Health (CVS), Gilead Sciences (GILD), Intel (INTC), Visa (V), The Coca-Cola (KO) and AbbVie (ABBV).

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the following people:
  • Mr. Dow R. Wilson, CEO & Director (Age 61, Pay $2.45M)
  • Mr. Christopher A. Toth, Pres & COO (Age 41, Pay $972.98k)
  • Ms. Kolleen T. Kennedy, Chief Growth Officer & Pres of Proton Solutions (Age 61, Pay $1.45M)
  • Mr. Jesse Michael Bruff, Sr. VP of Fin. & CFO (Age 51)
  • Mr. Magnus A. Momsen, Sr. VP, Chief Accounting Officer & Corp. Controller
  • Mr. Thomas Rodden, Sr. VP & Chief Information Officer
  • Mr. Anshul Maheshwari, VP of Investor Relations & Treasurer
  • Ms. Vy H. Tran, Chief Compliance Officer and Sr. VP of Regulatory Affairs & Quality Assurance (Age 47)
  • Mr. Michael D. Hutchinson, Sr. VP, Chief Legal Officer & Corp. Sec. (Age 49)
  • Mr. Mark Plungy, Director of PR

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

Who are Varian Medical Systems' major shareholders?

Varian Medical Systems' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.06%), State Street Corp (4.38%), Carlson Capital L P (0.85%), UBS Asset Management Americas Inc. (0.72%), Assenagon Asset Management S.A. (0.65%) and BNP Paribas Arbitrage SA (0.52%). Company insiders that own Varian Medical Systems stock include Christopher A Toth, Dow R Wilson, Gary E Bischoping Jr, John W Kuo, Kolleen T Kennedy, Magnus Momsen, R Andrew Eckert and Timothy E Guertin.
View institutional ownership trends for Varian Medical Systems

Which major investors are selling Varian Medical Systems stock?

VAR stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, BlackRock Inc., Boston Trust Walden Corp, Congress Asset Management Co. MA, AXA S.A., State Street Corp, Charles Schwab Investment Management Inc., and New York State Common Retirement Fund. Company insiders that have sold Varian Medical Systems company stock in the last year include Christopher A Toth, Dow R Wilson, John W Kuo, Kolleen T Kennedy, Magnus Momsen, and R Andrew Eckert.
View insider buying and selling activity for Varian Medical Systems

Which major investors are buying Varian Medical Systems stock?

VAR stock was acquired by a variety of institutional investors in the last quarter, including Carlson Capital L P, Assenagon Asset Management S.A., ARP Americas LP, DLD Asset Management LP, TIG Advisors LLC, BNP Paribas Arbitrage SA, Alpine Associates Management Inc., and MUFG Securities EMEA plc.
View insider buying and selling activity for Varian Medical Systems

How do I buy shares of Varian Medical Systems?

Shares of VAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of VAR stock can currently be purchased for approximately $173.90.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $15.81 billion and generates $3.23 billion in revenue each year. The medical equipment provider earns $291.90 million in net income (profit) each year or $4.63 on an earnings per share basis. Varian Medical Systems employs 10,062 workers across the globe.

What is Varian Medical Systems' official website?

The official website for Varian Medical Systems is www.varian.com.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, Palo Alto CA, 94304. The medical equipment provider can be reached via phone at 650-493-4000 or via email at [email protected]

This page was last updated on 11/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.